Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line

Haugen, 2004, Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids, J Clin Endocrinol Metab, 89, 272, 10.1210/jc.2003-030770 Dentice, 2004, Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells, Mol Cell Biol, 24, 7863, 10.1128/MCB.24.18.7863-7877.2004 Lee, 2004, In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene, Thyroid, 14, 889, 10.1089/thy.2004.14.889 Dulgeroff, 1994, Medical therapy for differentiated thyroid carcinoma, Endocr Rev, 15, 500 Schmutzler, 1997, Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells, Biochem Biophys Res Commun, 240, 832, 10.1006/bbrc.1997.7715 Chung, 2002, Sodium iodide symporter: its role in nuclear medicine, J Nucl Med, 43, 1188 Shen, 2004, Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy, Gene Ther, 11, 161, 10.1038/sj.gt.3302147 Dohan, 2003, Advances in Na(+)/I(−) symporter (NIS) research in the thyroid and beyond, Mol Cell Endocrinol, 213, 59, 10.1016/j.mce.2003.10.059 Schroder-van der Elst, 2004, Differential effects of natural flavonoids on growth and iodide content in a human Na*/I− symporter-transfected follicular thyroid carcinoma cell line, Eur J Endocrinol, 150, 557, 10.1530/eje.0.1500557 Spitzweg, 2003, Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells, Endocrinology, 144, 3423, 10.1210/en.2002-0206 Cho, 2000, Hormonal regulation of radioiodide uptake activity and Na+/I− symporter expression in mammary glands, J Clin Endocrinol Metab, 85, 2936, 10.1210/jc.85.8.2936 Mandell, 1999, Radioisotope concentrator gene therapy using the sodium/iodide symporter gene, Cancer Res, 59, 661 Gol Choe, 2005, Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray, Nucl Med Commun, 26, 1155, 10.1097/00006231-200512000-00017 Shimura, 1997, Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I− symporter gene, Endocrinology, 138, 4493, 10.1210/en.138.10.4493 Gruning, 2003, Retinoic acid for redifferentiation of thyroid cancer — does it hold its promise?, Eur J Endocrinol, 148, 395, 10.1530/eje.0.1480395 Altucci, 2001, The promise of retinoids to fight against cancer, Nat Rev Cancer, 1, 181, 10.1038/35106036 Huang, 2003, Retinoic acid-induced AP-1 transcriptional activity regulates B16 mouse melanoma growth inhibition and differentiation, J Cell Physiol, 194, 162, 10.1002/jcp.10199 Kogai, 2004, Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models, Cancer Res, 64, 415, 10.1158/0008-5472.CAN-03-2285 Schmutzler, 2002, The promoter of the human sodium/iodide-symporter gene responds to retinoic acid, Mol Cell Endocrinol, 189, 145, 10.1016/S0303-7207(01)00735-3 Kogai, 2000, Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line, Proc Natl Acad Sci U S A, 97, 8519, 10.1073/pnas.140217197 Hsiao, 2000, Prospective use of DNA microarrays for evaluating renal function and disease, Curr Opin Nephrol Hypertens, 9, 253, 10.1097/00041552-200005000-00008 Vawter, 2001, Application of cDNA microarrays to examine gene expression differences in schizophrenia, Brain Res Bull, 55, 641, 10.1016/S0361-9230(01)00522-6 Schmutzler, 2001, Regulation of the sodium/iodide symporter by retinoids — a review, Exp Clin Endocrinol Diabetes, 109, 41, 10.1055/s-2001-11017 Nishikori, 2003, High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease, Blood, 101, 2789, 10.1182/blood-2002-08-2464 Nolan, 1993, The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner, Mol Cell Biol, 13, 3557, 10.1128/MCB.13.6.3557 Watanabe, 1997, Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50–p105 and nuclear translocation, EMBO J, 16, 3609, 10.1093/emboj/16.12.3609 Barkett, 1999, Control of apoptosis by Rel/NF-kappaB transcription factors, Oncogene, 18, 6910, 10.1038/sj.onc.1203238 Starenki, 2004, Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells, J Clin Endocrinol Metab, 89, 410, 10.1210/jc.2003-031216 Pacifico, 2004, Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas, J Biol Chem, 279, 54610, 10.1074/jbc.M403492200 Erkel, 1996, Inhibition of NF-kappa B activation by panepoxydone, Biochem Biophys Res Commun, 226, 214, 10.1006/bbrc.1996.1335 Shotwell, 2002, Inhibitors of NF-kappaB signaling: design and synthesis of a biotinylated isopanepoxydone affinity reagent, Bioorg Med Chem Lett, 12, 3463, 10.1016/S0960-894X(02)00769-2 Battista, 1998, Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo, Oncogene, 17, 377, 10.1038/sj.onc.1201953 Nagpal, 1995, Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha, J Biol Chem, 270, 923, 10.1074/jbc.270.2.923 Salbert, 1993, Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity, Mol Endocrinol, 7, 1347, 10.1210/me.7.10.1347 Chuikin, 2004, Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells, Tsitologiia, 46, 1080 Muller, 1984, Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes, Nature, 311, 438, 10.1038/311438a0 de Groot, 1991, Up-regulation of Jun/AP-1 during differentiation of N1E-115 neuroblastoma cells, Cell Growth Differ, 2, 631 Kindregan, 1994, Characterization of conventional protein kinase C (PKC) isotype expression during F9 teratocarcinoma differentiation. Overexpression of PKC alpha alters the expression of some differentiation-dependent genes, J Biol Chem, 269, 27756, 10.1016/S0021-9258(18)47050-0 Lee, 2004, Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells, J Neurochem, 91, 634, 10.1111/j.1471-4159.2004.02770.x Onose, 1999, Overexpression of fibroblast growth factor receptor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures, Eur J Endocrinol, 140, 169, 10.1530/eje.0.1400169 Vasko, 2003, Specific pattern of RAS oncogene mutations in follicular thyroid tumors, J Clin Endocrinol Metab, 88, 2745, 10.1210/jc.2002-021186 Garcia-Rostan, 2003, Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer, J Clin Oncol, 21, 3226, 10.1200/JCO.2003.10.130 Eggo, 1995, Expression of fibroblast growth factors in thyroid cancer, J Clin Endocrinol Metab, 80, 1006, 10.1210/jc.80.3.1006 Stolf, 2003, Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas, Cancer Lett, 191, 193, 10.1016/S0304-3835(02)00679-1 Aldred, 2004, Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes, J Clin Oncol, 22, 3531, 10.1200/JCO.2004.08.127 Weber, 2005, Genetic classification of benign and malignant thyroid follicular neoplasia based on a 3-gene combination, J Clin Endocrinol Metab, 15, 15